Nirland Limited 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-20 4:32 pm Sale |
2025-02-19 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 0 0.000% |
-153,500 (Position Closed) |
Filing |
| 2025-01-21 5:00 pm Purchase |
2025-01-13 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 153,500 9.979% |
133,500 (+667.50%) |
Filing |
| 2024-10-18 4:15 pm Sale |
2024-10-11 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 20,000 2.000% |
-60,920 (-75.28%) |
Filing |
| 2024-10-07 7:36 pm Sale |
2024-10-04 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 80,920 8.300% |
-64,080 (-44.19%) |
Filing |
| 2024-08-13 4:29 pm Purchase |
2024-08-06 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 145,000 14.800% |
79,797 (+122.38%) |
Filing |
| 2023-10-02 4:30 pm Purchase |
2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 65,203 8.800% |
65,203 (New Position) |
Filing |